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Abstract
Microglia are specialized immune cells of the brain. Upon insult, microglia initiate a cascade of cellular responses including a
characteristic change in cell morphology. To study the dynamics of microglia immune response in situ, we developed an
automated image analysis method that enables the quantitative assessment of microglia activation state within tissue
based solely on cell morphology. Per cell morphometric analysis of fluorescently labeled microglia is achieved through local
iterative threshold segmentation, which reduces errors caused by signal-to-noise variation across large volumes. We
demonstrate, utilizing systemic application of lipopolysaccharide as a model of immune challenge, that several
morphological parameters, including cell perimeter length, cell roundness and soma size, quantitatively distinguish resting
versus activated populations of microglia within tissue comparable to traditional immunohistochemistry methods.
Furthermore, we provide proof-of-concept data that monitoring soma size enables the longitudinal assessment of microglia
activation in the mouse neocortex imaged via 2-photon in vivo microscopy. The ability to quantify microglia activation
automatically by shape alone allows unbiased and rapid analysis of both fixed and in vivo central nervous system tissue.
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Introduction
Microglia are the native innate immune cells of the central
nervous system. In response to insult, they become activated,
migrate to sites of damage, phagocytose cellular debris, and release
cytokines [1]. This response is thought to rapidly mitigate local
infection and cell damage. However, chronic activation of
microglia has been implicated as a causative factor in a range of
neurological disorders [2]. The dichotomy of microglia biology in
health and disease is poorly understood due, in part, to a lack of
methods to efficiently quantify microglia activation longitudinally
in the context of their cellular environment.
Mechanical, metabolic or inflammatory activation of microglia
results in several characteristic physiological changes within
individual cells. Microglia undergo a shift in gene expression
profile [3,4,5]; Notably, expression of the calcium binding protein
IBA-1 [6] and the lysosomal protein CD68 [7] are up-regulated.
Consequently, immunohistochemistry detection of IBA-1 and/or
CD68 is routinely used to assess activation within tissue. However,
histological approaches do have limitations, for example they are
incompatible with the longitudinal assessment of individual
microglia in situ.
Another characteristic activation-induced change in microglia is
a transformation in cellular morphology [1]. At rest microglia
exhibit a ramified cell morphology with numerous thin processes
extending tens of microns away from their soma. Upon activation,
these thin processes are drawn back into their soma, resulting in a
rounded amoeboid-like appearance. Recent work suggests that this
change in morphology may provide an opportunity to quantita-
tively study microglia activation within their native cellular context
longitudinally.
Utilizing time-lapse imaging of FITC labeled microglia within
neonatal rat brain slices, Stence and colleagues demonstrated that
microglia undergo a stepwise change in cell morphology with
activation [8]. Specifically, mechanical activation induced the
retraction of fine processes on timescales of minutes prior to
changes in cell motility. Measures of processes length, therefore,
enabled the quantification of activation response on a per cell
basis.
The use of morphological change as a readout of microglia
activation is further supported by studies comparing cell
morphology to the expression level of known markers of
microglia activation. P2Y12 is a metabotropic purinergic receptor
down-regulated within microglia under activating conditions [9].
By comparing the expression level of P2Y12 after mechanical
insult to the number of primary processes emanating from a
microglia, Haynes and colleagues demonstrated a positive
correlation (R
2=0.93) between process number and P2Y12
expression, consistent with microglia converting to an amoeboid
shape upon activation.
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measurement of microglia morphology. Manual methods are time
consuming, susceptible to human bias, and therefore difficult to
scale up to analyze larger datasets. To circumvent these
limitations, we sought to develop automated image analysis
methods to segment the cell shape of individual microglia from
fluorescence micrograph datasets, calculate morphological param-
eters that characterize individual cell shape, then quantitatively
assess which parameter best reports changes in microglia
activation state.
Here, we report the implementation of an iterative thresholding
method to segment the cell shape of individual microglia with
,90% accuracy compared to manual methods, yet that requires
,1/100th the time, and no human intervention. Segmentation
relies on a priori knowledge of a single characteristic of microglia:
cell size. Utilizing this automated segmentation method in parallel
with immunohistochemistry staining for known markers of
microglia activation, we demonstrate that automated measures
of microglia morphology can be used to quantify their activation
state in tissues, on a per cell basis. We find that soma size best
correlates with expression level of IBA-1 under activating
conditions. Finally, in a proof-of-concept study we illustrate the
utility of tracking soma size longitudinally as a quantitative metric
of microglia activation in vivo. The ability to automatically track
microglia activation without antibody staining will expedite the
study of microglia biology and their role in disease.
Materials and Methods
Ethics Statement
All procedures were carried out with Institutional Animal Care
and Use Committee (IACUC) approval in accordance with the
institution’s ethical guidelines (Genentech Protocol Numbers: 2-
photon intravital imaging 08-1737, immunohistochemistry 10-
1389).
Animals and treatment conditions
Two to four-month old CX3CR1-EGFP heterozygous C57BL/6
animals[10]wereusedforallexperiments.Microgliawereactivated
in vivo by I.V. injection of 1, 2 or 4 mg/kg of Escherichia coli LPS
(serotype EH100 Sigma) dissolved in 0.9% saline. These mice were
euthanized after 24 h or 48 h (as indicated) for histological analysis.
An independent set of animals were examined in vivo by 2-photon
microscopy through a cranial window, 6 LPS treatment or laser
ablation, and imaged up to 96 h.
Confocal Microscopy of ex vivo tissues
Coronal sections of 40-mm thickness were prepared on a
cryostat and mounted onto slides (see Immunohistochemistry).
Cortical regions of the coronal sections were examined using an
inverted laser scanning confocal microscope (SP5 Leica with multi-
immersion objective 2060.7 NA), with excitation lasers at 488 nm
and 633 nm to excite EGFP (bandpass 510/20 nm) and Alexa 647
(bandpass 675/25 nm), respectively. The laser was then tuned to
533 nm to excite Alexa-564 (bandpass 615/30 nm), to avoid
bleed-through of EGFP into the Alexa-564 channel. Two regions
per mouse, covering 7766776 mm, ,10 optical sections 1 mm
apart (0.76 mm/pixel resolution in X and Y), were imaged with
three line averaging to reduce noise.
Generating maximum intensity projections
All segmentation and quantification was performed on 2D mean
intensityprojections(MIPs)of3Dimagedata.Forfixedsamples,the
top 10 mm were used to create MIPs from cortical regions. The
imaged depth approximately corresponds to the antibody penetra-
tion depth. For in vivo data, image volumes of 100 mm axial depths
were obtained. Sub-volumes of 10 mm thickness were used to create
MIPs, separated by 20 mm gaps, resulting in three MIPs analyzed
per imaged volume. As soma size is approximately 10 mmi n
diameter, we reasoned that the 20 mm gap between volumes used
for maximum projections eliminated the possibility of the same cell
being identified within multiple MIPs.
Image segmentation
All morphometric segmentation was based on green fluores-
cence intensities generated from imaging EGFP expressing
microglia of CX3CR1-EGFP transgenic mice. The automated
segmentation routine consists of three steps:
First, the positions of individual cells within a field of view were
determined by: 1) identifying objects consisting of connected pixels
with intensity values above a regional maxima intensity value
(imregionalmax function within MATLAB), then 2) calculating the
centroid for each object detected with a summed pixel area greater
than 50 mm
2. Each centroid defined an individual microglia cell
positions (CP).
Second, cell masks (CM) were generated per CP via iterative local
threshold segmentation of EGFP+ pixels. Specifically, within a
120 mm6120 mm local region (LR) centered on each CP, candidate
cell masks (CCM) were generated by identifying connected pixels
with intensity values greater than the threshold calculated by Otsu’s
method [11] within the LR. Otsu’s method identifies a threshold
pixel value that minimizes the interclass pixel intensity variance
between the two pixel classes (‘on’ or ‘off’) within the image
(graythresh function within MATLAB). The summed pixel area
within a CCM is compared to the predetermined variable, target
cell size (TCS, discussed further in Target cell size). If the CCM equals
the TCS 6 100 mm
2 the mask is considered to be an accurate CM
for the associated CP. If not, the threshold is adjusted by a quantity
proportional to the difference between the current CCM size and
TCS averaged over every past iteration (Figure S1). The iteration
stops when either the CCM is within an accepted range of the TCS
6 100 mm
2 or if the size of the CCM stabilizes to a fixed value for
more than two consecutive iterations at which point the mask is
considered to be an accurate CM for the associated CP. This
averaging method ensures that the calculations converge.
Third, each CM is subject to two subsequent tests to confirm it
accurately represents a single microglial cell. Test 1: Does the CM
touch the boundary of the LR, thus potentially misrepresent the
area of the cell? If so, the CP and CM are removed from further
analysis. Test 2: Does the CM contain a single soma? A cell soma
mask (CSM) is defined as a contiguous area larger than 16.7 mm
2
within the CM with pixel values 50% greater than the rest of the
CM. If the CM contains more than one CSM it is excluded from
further analysis as it likely represents a dividing cell or two cells in
close proximity that could not be accurately resolved. If a CM does
not contain a CSM it is also discarded, as it likely represents a
microglia positioned above or below the imaged volume.
Morphometric measures of cell shape
At rest microglia exhibit a ramified morphology, yet become
amoeboid upon activation. To quantitatively describe this
morphological switch we defined a series of morphological
parameters expected to capture this change. These include cell
perimeter length, the length around the periphery of each cell; cell
spread, the average distance from the cell center of mass to its
detected extremes; eccentricity, the ratio of the major axis to the
minor axis of the smallest circle that can fit the extensions of
the cell; roundness, 4p6area/cell perimeter length
2; soma size, the
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calculated from individual segmented soma or cell masks (see Image
segmentation) using the MATLAB regionprops function with the
properties specified as: perimeter, extrema, eccentricity and area,
respectively.
Immunohistochemistry and automated quantification of
protein expression per cell
Animals were euthanized by CO2 asphyxiation and immediately
transcardially perfused with PBS followed by 10% sucrose 4%
paraformaldehyde in PBS. Whole brains were placed in the same
fixative overnight and then transferred into 30% sucrose. Coronal
sectionsof40 mmthicknesswerepreparedonacryostatandmounted
onto slides. Sections were permeabilized (0.1% Triton in PBS),
blocked 1 h at room temperature (5% BSA 0.3% Triton in PBS),
immuno-stained with 1:1000 rabbit anti-IBA-1 (Wako Chemicals) or
1:500 rat anti-CD68 (Serotec) overnight at 4uC. Sections were
washed (0.1% Triton in PBS) and secondary antibodies 1:1000 anti-
rabbit Alexa-564 and anti-rat Alexa-647 (Invitrogen Molecular
Probes), respectively, were applied for 2 h at room temperature.
Sections were mounted with VectaShield (Vector Labs).
Similar to cell shape segmentation, quantification of immunoflu-
orescence data can be complicated by inhomogeneity of fluores-
cence intensities across a large field of view. Often, fluorescence
intensities are quantified by measuring overall image brightness,
and subtracting the mean background fluorescence. Since our work
is concerned with fluorescence intensities in individual microglia,
each cell was analyzed within its local region of interest as defined
during image segmentation (Figure S5). IBA-1 or CD68 expression
was quantified within each cell mask based on secondary antibody
fluorescence intensity. The mean fluorescence intensity was divided
by the mean background intensity within LR. The mean
background intensity was calculated from the mean intensity within
the LR excluding the cell mask. This quotient method was used
instead of a subtractive method, as the former provided more
consistent results with tissues of varying staining intensities.
Target cell size (TCS)
Our segmentation routine utilizes a single variable, TCS, to
minimize the impact of local fluorescence intensity variability in
segmenting individual cells, and thus can potentially influence the
values calculated for the parameters characterizing microglia
morphology. Initially, this value was estimated based on the
approximate size of individual microglia when represented in
MIPs of 10 mm volumes 7006700 mm
2 XY fields of view. Once
the segmentation routine, morphological parameters and immu-
nostaining techniques were established, we further explored the
influence of the TCS on the ability to distinguish LPS-induced
microglia activation from control (Figure S2). We found that a
TCS of 5006100 mm
2 gave the highest number of detected CMs
and highest differentiation between activated and resting microglia
by both morphological and marker expression matrices. Further-
more, the value of 500 mm
2 is consistent with previous estimates of
microglia size in the CNS [12]. Note that if the target cell size is set
too high, it will detect not only cells, but also neighboring touching
cells. If it is set too low, its ability to distinguish activated and
resting cells diminish, as the main delineating factor is expected to
be cell process extensions. For all analysis in this text, TCS was
therefore set to 500 mm
2.
2-photon in vivo microscopy
Cranial windows were implanted above the somatosensory
cortex as described previously [13]. Briefly, animals were
anesthetized using isoflurane, secured on a stereotax, and a
craniotomy was performed to remove approximately a 2-mm
diameter region of skull leaving the dura intact. A custom-made 3-
mm diameter No. 1 glass cover slip was placed above the exposed
tissue and secured to the remaining bone with dental acrylic. A
metal bar was embedded within the dental acrylic next to the glass
and used to secure the mouse at a fixed angle during imaging.
Mice were allowed to recover a minimum of two weeks before
beginning an imaging experiment.
For each imaging time point, mice were anesthetized with 1–2%
isoflurane and injected I.V. with 100 ml of the vascular marker
AngioSense 680 (VisEn Medical). Animals were head restrained at
the stage of a 2-photon microscope equipped with four
independent photomultiplier tubes (Prairie Technologies Ulti-
maIV) and powered by a tunable MaiTai DeepSee Ti-sapphire
laser (Spectra-Physics). Images were acquired using a 406 N.A.
0.8 objective (Olympus), 910 nm excitation wavelength, 440/
80 nm, 510/60 nm and 705/50 nm bandpass filters for second
harmonic detection of the dura, EGFP+ and AngioSense 680,
respectively. Laser power and dwell time were constant within an
experiment (,20 mW back focal plane power, 4.8 ms/pixel,
respectively). Only those areas between 50 mm and 200 mm below
the dura were used for imaging. For the first imaging session, up to
3 neighboring 30063006100 mm (XYZ) areas were imaged
(5126512 pixels spaced 1 mm in Z, 0.58 mm/pixel resolution in
X and Y). For subsequent imaging sessions, imaging areas were
identified via the unique patterning of the vasculature. Note: daily
I.V. administration of AngioSense, a macromolecular fluorescent
probe with relatively slow systemic clearance, resulted in a gradual
increase in red fluorescence within the vasculature throughout the
longitudinal studies.
Statistics
Statistical analysis was performed using the MATLAB Statis-
tical Package. Results are shown as mean values 6 standard
deviations (STD). Statistical significance is calculated by Student’s
T-test, and indicated as follows: *p,0.05, **p,0.01, and
***p,0.001. Correlation was calculated by Pearson’s Correlation
Formula.
Results
Automated segmentation of fluorescently labeled
microglia
At rest microglia exhibit a ramified morphology: thin processes
extending tens of microns radial from a larger cell soma. This
shape provides unique challenges for automating cell segmentation
from fluorescent micrographs using standard global threshold
methods. For example, subtle inhomogeneities in fluorescence
excitation or detection across a field of view can influence
fluorescence intensity values across an image and even a single cell.
In the context of fluorescently labeled microglia this translates to
errors when segmenting thin processes. To circumvent this
problem we developed an iterative local threshold method, which
enables the segmentation of microglia within tissues at accuracies
comparable to manual segmentation (see Materials and methods).
Briefly, our segmentation strategy relies on three steps (Figure 1).
1) The identification of microglia cell positions (CP) within a field
of view, achieved through a regional maxima finding algorithm. 2)
Applying an iterative threshold segmentation routine within the
local region surrounding each detected CP to generate an accurate
cell mask (CM) (Figure S1 and Figure S2). 3) Post-segmentation
testing to verify that each CM accurately represents a single cell
with a single soma. Furthermore, since segmentation does not
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approach is relatively insensitive to pixel saturation.
When implemented in MATLAB, the computing time per cell
within a field of view is approximately 0.2 seconds. Overall, 70 to
100% of cells detected by manual segmentation methods are
correctly identified by this automated algorithm (Figure S3). Note
that due to their ramified morphology, processes from resting cells
are more likely to touch neighboring cells, thus fewer resting cells
are properly segmented per area compared to activated cells.
Similarly, conditions that result in microglia aggregation may
result in fewer detected cells as their probability of contact
increases with increasing proximity.
Per cell morphometric characterization of microglia
within tissue
Once segmented, each cell mask provides the spatial coordi-
nates of individual microglia. To quantitatively describe their
shape, we defined a series of morphometric parameters designed
to capture the ramified morphology of resting microglia
(Figure 2A), see Material and Methods. These include cell
perimeter length; cell spread, which is analogous to the ‘process
length’ metric from previous studies [8]; eccentricity; roundness,
which is similar to the morphology quantification used by Haynes
et al. [9]; and soma size. Once implemented into the image
analysis routine post-segmentation, these morphological parame-
ters could be automatically calculated per cell en masse ,100 times
faster than equivalent manual methods (Figure S3). Within
populations of cortical microglia cell perimeter length, cell spread
and soma size exhibit a normal distribution with mean values of
468689 mm, 29.767.7 mm, 27.764.5 mm
2, respectively (Figure
S4). Roundness and eccentricities, conversely, exhibit skewed
distributions with median values of 0.0283 (first quartile=0.0218,
third quartile=0.0321) and 0.787 (first quartile=0.716, third
quartile=0.892), respectively.
Morphometric-based quantification of microglia
activation
Upon activation, microglia undergo a characteristic morpho-
logical transformation in which they take on an amoeboid-like
shape. To test if our automated segmentation and morphometric
analysis methods enable quantitative assessment of this activation-
induced morphological switch, we compared the calculated values
as a function of LPS-induced activation condition. LPS induces
microglia activation through the TLR4 pathway; Systemic
application of LPS is commonly used to activate these cells in vivo.
CX3CR1-EGFP heterozygous animals were injected I.V. with
varying doses of LPS (0, 1, 2, and 4 mg/kg) 24 h prior to
collection. For each LPS condition, the calculated morphometric
parameters were normalized to control condition (0 mg/kg) values
and plotted as a percentage, where the mean values in the control
sample are defined as 100% (Figure 2B). Strikingly, several
parameters exhibited a significant change as a function of injected
LPS dose: roundness and soma size increased (roundness:
10669%, 126619% and 213644%; soma size: 124612%,
133617% and 170629% for 1, 2 and 4 mg/kg doses of LPS,
respectively; mean 6 STD) while cell perimeter length decreased
(9863%, 9268% and 74610% for 1, 2 and 4 mg/kg doses of
LPS, respectively; mean 6 STD). Soma size was the only
parameter tested that exhibited a significant change compared
to control over the entire LPS dose range.
To confirm systemic LPS injection induced microglia activation
over the dose range, we examined condition-dependent expression
of IBA-1 and CD68, as expression of both proteins increase in
activated microglia [6,14]. Cortical sections from CX3CR1-EGFP
heterozygous animals were immunostained for IBA-1 and CD68
using red and infrared fluorophore linked secondary antibodies,
respectively, and then imaged to detect green, red and infrared
fluorescence. Cell masks, identified through segmentation of
EGFP signal, were used as cell-specific regions of interest for
quantifying immunofluorescence within individual microglia
(Figure 2B and Figure S5). With LPS treatment both IBA-1 and
CD68 detection increased within cells (IBA-1: 11569%, 12268%
and 13063%; CD68: 109611%, 109612% and 11064% for 1, 2
and 4 mg/kg LPS injected, respectively; mean 6 STD), however
only IBA-1 exhibited a significant increase over the entire LPS
dose range. The concurrent dose-dependent increase in IBA-1
expression and measured change in cell shape, specifically soma
size, suggests that morphometric analysis of microglia proves a
quantitative method for assessing microglia activation in situ.
The ability to quantify cell shape and protein expression level on
a per cell basis within a large population provides an opportunity
Figure 1. The image processing strategy for segmenting cell
shape of individual microglia. Cell positions (CP, blue cross) within
a maximum intensity projection were identified by a local maxima-
finding algorithm. Within a 1206120 mm local region (LR, white square)
centered per CP, cell masks (CM) are segmented through an iterative
local threshold algorithm. For each CM, a cell soma mask (CSM) is
defined as an object with pixel values greater than the last iterative
threshold+50% and contiguous area greater than 16.7 mm
2. A CM (red
outline) and CSM (white outline) are considered accurate representa-
tions of a cell (bottom figure) if the CM is not touching the edge of the
LR boundary and has a single CSM. Scale bar equals 50 mm.
doi:10.1371/journal.pone.0031814.g001
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regulation and LPS-induced activation. We tested if our
automated measurements are capable of revealing per cell
relationships by comparing the detected expression level of IBA-
1 versus CD68 under the various LPS condition (Figure 3 and
Figure S6). In all conditions, IBA-1 and CD68 expression were
correlated (mean R
2.0.3); however, there is significant heteroge-
neity within any given population. Even at the highest LPS dose,
subsets of cells exhibited low expression of IBA-1 and CD68,
suggesting that not all microglia activate in vivo with systemic
injection of LPS.
We extended this analysis to test which, if any, morphological
parameters correlate with IBA-1 expression on a per cell basis.
Within a given LPS condition, cell perimeter length, roundness,
and soma size correlated with each other (data not shown).
However, only soma size exhibited a per cell correlation (mean
R
2.0.3) with IBA-1 expression in multiple LPS conditions
(Figure 3 and Figure S6), further supporting the use of soma size
as a morphological surrogate to assess microglia activation in situ.
Longitudinal measure of microglia activation in vivo
The correlation between soma size and expression of
microglia activation markers suggests this morphological feature
may provide a method to monitor microglia activation
longitudinally within native tissue. To test this, we quantified
soma size and the expression of IBA-1 and CD68 as a function of
time from cohorts of CX3CR1-EGFP heterozygous animals
dosed 1 mg/kg or 2 mg/kg LPS 0, 24 or 48 h prior to tissue
Figure 2. Morphometric parameters that quantitatively cap-
ture LPS-induced microglia morphology change. (A) Morpho-
logical parameters defined to characterize the shape of segmented
cells: cell perimeter length, cell spread, eccentricity and soma size. Scale
bar equals 50 mm. (B) Relative change in microglia morphometric
parameters, IBA-1 and CD68 expression as a function of LPS dose. For
each LPS condition, a mean value for each morphological parameter is
calculated per animal, which is then normalized to the average value for
that parameter in the control group (0 mg/kg LPS). This relative value
per animal is then used to calculate a mean value and standard
deviation per condition, as plotted, n=7, 6, 6 and 5 animals/condition,
respectively. Asterisks indicate statistical significance compared to
0 mg/kg LPS (see Materials and Methods), those over horizontal lines
indicate statistical significance between conditions.
doi:10.1371/journal.pone.0031814.g002
Figure 3. Correlation between morphological parameters and
IBA-1 expression. Correlation plots between IBA-1 expression and
CD68 expression or the various morphometric parameters, under
control and 4 mg/kg LPS conditions (n=7 and 5 animals/group,
respectively). Cell populations from individual mice are plotted in
different symbols. The numbers indicates the mean linear correlation
coefficient (R
2) value per comparison derived from linear fits to each
animal dataset within a condition.
doi:10.1371/journal.pone.0031814.g003
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expression, exhibited time-dependent increases most pronounced
in the 2 mg/kg dose, suggesting that the time course of LPS-
dependent microglia activation could be assessed by monitoring
soma size.
To test this possibility further, we conducted proof-of-concept in
vivo imaging studies. First, we tested if differences in imaging
properties across microscopes, such as pixel size and optical
section thickness, significantly influences estimates of soma size.
Varying either parameter did not influence calculated values
Figure 4. Longitudinal assessment of microglia activation in vivo by tracking changes in soma size. (A) Quantification of soma size, IBA-1
and CD68 expression relative to control conditions 24 or 48 hours post LPS injection. Asterisks indicate significance for each condition compared to
control (0 mg/kg LPS, 24 h), horizontal line represents statistical comparisons between indicated time points, n=5, 6, 6, 6 and 6 animals/group,
respectively. (B and C) Top: representative images of microglia (green) and blood vessels (red) imaged in vivo at indicated time points. Bottom:
Outlines of segmented microglia from the corresponding image above color-coded to indicate soma size per cell under control (B) and LPS (2 mg/kg)
(C) conditions; red corresponds to microglia with soma size .65 mm
2, thus activated. (D) Quantification of soma size measured in vivo as a function
of time and LPS dose. Data from one control animal, and one LPS stimulated animal, are shown. Scale bar equals 50 mm.
doi:10.1371/journal.pone.0031814.g004
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through a cranial window by 2-photon microscopy. In control,
microglia were imaged daily for 3 consecutive days (Figure 4B), no
change in soma size was detected (Figure 4D). Injection of 2 mg/
kg LPS, however, induced a time-dependent change in soma size:
a 2-fold increase over the initial 48-hour time period, with similar
timing and magnitude as measured ex vivo, before subsiding to near
resting levels by 96 hours (Figure 4C and 4D). Similar time-
dependent changes in microglia soma size were observed following
I.P. injection of LPS across a population of animals enabling
quantitative assessment of microglia activation/resolution (Ko-
zlowski and Weimer, unpublished), thus supporting the use of the
image analysis routine outlined here in quantifying microglia
activation dynamics.
To test if soma size could be used to track microglia activation
under conditions other than LPS stimulation, we utilized focal
thermal damage to activate microglia. Small (56565 mm) cortical
regions were targeted for laser ablation and associated areas
imaged over four days. Within three cortical regions, targeted focal
ablation induced an increase in the average soma size of nearby
microglia. In adjoining regions away from the ablation site,
microglia soma size remained unchanged (Figure S8). Taken
together, these data suggest that monitoring the change in soma
size provides a longitudinal readout of microglia activation in a
range of activation conditions.
Discussion
In this work, we describe an automated image analysis method
capable of accurately segmenting individual fluorescently labeled
microglia from in situ image data and calculating morphological
parameters that describe their shape, enabling the rapid analysis of
large populations. Segmentation is achieved through a novel local
iterative threshold method, which relies on a single variable, target
cell size. Furthermore, we provide evidence that microglia
activation can be quantified in situ based on morphometric
analysis of microglia; specifically, one parameter, soma size,
exhibits an LPS dose-dependent increase concurrent with
increasing IBA-1 expression. We also provide proof-of-concept
data demonstrating that longitudinal assessment of soma size
provides a quantitative means to capture the dynamics of
microglia insult response in vivo under LPS and thermal-injury
activating conditions.
One of the greatest challenges in automatically detecting cell
morphology from fluorescence microscopy data is compensating
for uneven fluorescence detection across a field of view. This is of
particular importance when relying on subtle changes in cell
morphology as readout of cell physiology. If background levels
vary widely between image regions, applying a global threshold
will result in non-uniform identification of cell shape dependent
upon where the cell is located in the field of view. In the context of
microglia, highly ramified cells, resting cells may appear more
rounded, and therefore activated, if a slightly higher intensity
threshold is used to segment the image. We overcame this problem
by first detecting the positions of the cells within a field of view by
utilizing regional maxima finding algorithm. Accurate cell
segmentation could then be achieved by applying a local iterative
threshold operation within the immediate area surrounding each
detected soma. In this manner we could achieve 70–100%
accuracy in cell detection and segmentation at ,1/100
th the time
required for manual intervention.
The morphometric analysis described above relies on segmen-
tation of two-dimensional projection representing a three dimen-
sional volume. As the distribution of branches from a microglia
appears to be random at rest with respect to X, Y and Z
dimensions [12], analysis of branching in a three dimensional
volume projection should provide a representative estimate of total
cell shape and branching pattern. A projection through 10 mmo f
Z depth, we show, is sufficient to quantitatively assess changes in
microglia shape. The Z depth of 10 mm is also of importance as it
enables consistent analysis of cell shape and immunostaining
within tissue sections where antibody penetration is limited.
The cell segmentation method outlined in the manuscript is
directly applicable to defining cell-based ROIs to quantify
fluorescent intensities of various different markers. The ability to
measure cell shape change is dependent on contrast across the
labeled cell, and therefore, will only be compatible with labeling
methods that provide staining throughout the cell. Care should be
taken to analyze markers that vary in staining intensity with
microglia activation, such as IBA-1. This is because activated cells
will be easier to detect than resting cells, potentially introducing bias.
Several imaging modalities enable the quantitative measure of
microglia activation in vivo. Positron emission tomographic
imaging of benzodiazepine receptor radioligands, for example,
quantitatively report the upregulation of PBR expression induced
upon microglia activation [15]. Preclinical magnetic resonance
and bioluminescence imaging methods are also emerging for
assessing neuroinflammation in vivo [16,17,18]. While powerful for
assessing gliosis on a whole organ basis, these techniques are
limited in both spatial resolution and temporal flexibility.
Conversely, the image analysis routines and microscopy
techniques utilized in this study enable the quantitative assessment
of microglia activation within large regions of the cortex
longitudinally in vivo with cellular resolution and on timescales of
seconds to months. Automated image segmentation provides a
rapid unbiased method, enabling analysis of large datasets
consisting of numerous imaging volumes and/or multiple time
points. Furthermore, our morphometric analysis extends previous
microscopy-based studies [8,19,20], and supports its use as a
quantitative metric of microglia activation.
The methods outlined above should also be directly applicable
to the study of microglia biology in other nervous system tissue, or
insult conditions; however, the morphological metrics should be
recalibrated to match the experiment. For example, the morphol-
ogy of resting microglia can vary with the nervous system region
[12]. Therefore, the morphometric parameters used for assessing
activation should be confirmed per region and microglia
morphologies compared only within the same region.
Finally, the morphology analysis method here is not limited to
the study of microglia. There are other cell types, such as dendritic
cells that undergo considerable morphology change with activa-
tion [21]. These methods could be used to rationally construct
shape-based activation indicators for cell activation time-course in
vivo.
Supporting Information
Figure S1 Convergence of cell size by iterative threshold
segmentation. (A) A MIP image of a typical microglia. (B)
Example of segmented CCM when an estimated intensity
threshold is set too high (exaggerated for illustrative purposes).
This gives a CCM with a very small area and does not capture the
features of the cell. The iterative method ensures that the threshold
is modified at each iteration, so that the detected cell size
eventually converges* near the TCS** (C). (D) Similarly, if a
threshold is too low initially, the iterative method ensures that the
CCM area converges to a similar (in this case identical) value as in
(C). (E). Note that both iterative methods produce segmented
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that in D). All images are of the same scale. Scale bar equals
50 mm. * Typically, the starting image threshold estimate by the
Otsu method using the MATLAB graythresh function generates a
CCM closer to the final CM than the thresholds used in this
illustration, which are examples of ‘‘worst case’’ scenarios. In order
to investigate the robustness of the convergence algorithm under
these conditions, we substituted the typical Otsu estimated starting
image threshold with either Otsu threshold divided by 2 or
multiplied by 2. This is a wide range that should safely encompass
any errors that would normally arise from the initial threshold
estimation. The mean differences between the cell sizes obtained
from these different starting thresholds were computed as:
abs CMT=2-CMTx2

=CMTx2
Where CMT/2=cell mask size obtained from using half the Otsu
value for a starting threshold; CMTx2=cell size obtained from
using double the Otsu value for a starting threshold. Computed for
10,000 cells, the average value was 8.10%, showing that even in
the worst case scenario, the mean error in convergence is relatively
small: less than 10%. **For the method used to determine the
optimal TCS, see Figure S2.
(TIF)
Figure S2 Dependency of morphometric parameter
threshold values. (A) The influence of TCS on morphometric
parameters and detected IBA-1 and CD68 expression, for control,
2 mg/kg, and 4 mg/kg doses of LPS in fixed (IHC) samples. TCS
value of 500 mm
2 provided maximal cell detection and the ability to
distinguish between LPS conditions based on measured parameters.
(B) Effect of threshold level on soma size detection in both live and
fixed samples. The soma mask is identified utilizing a threshold
value x above the last iterative threshold used to segment the entire
cell. When x is increased from 0.1 to 0.9, there is a decrease in
recorded soma size. However, for whatever value of x, the results
delineated between microglia from LPS stimulated, and control
samples. This implies that the exact value of x will not influence the
ability to differentiate between activated and control microglia.
(TIF)
Figure S3 Comparisons of manual and automated
methods to detect cells. (A) Examples of manual and
automatic cell detection of microglia under different LPS
conditions 24 h prior to tissue collection. The primary processes
were manually scored (red spots). Only cells that are fully in focus
(the soma is visible), and not touching the border of the frame or
other cells, are counted. The right shows automatically segmented
cells in various colors, and white circles that indicate the detected
cell bodies. Scale bar equals 50 mm. (B) Summary of the time
taken, total number of detected cells, the total number of processes
detected, and the average number of processes per cell detected by
the manual or automatic method. Note that counting processes
manually is very difficult, because of the ‘fractal-like’ shape of
microglia, where small processes extend from larger processes.
Therefore, the manual method must arbitrarily determine the size
of a process that is large enough to be counted.
(TIF)
Figure S4 Distribution of Morphometric Parameters,
IBA-1 and CD68 expression per cell in control samples.
Histogram plots of the distribution of morphometric parameters,
and IBA-1 and CD68 expression assessed from n=5 animals
under control conditions.
(TIF)
Figure S5 Per cell quantification of IBA-1 and CD68
expression. Cell-specific regions of interest defined through
segmentation of individual microglia based on EGFP fluorescence
(white outline). Protein expression within each ROI is quantified
based on fluorescence intensity of the corresponding secondary
antibody label before any contrast adjustment. For illustration, the
images are contrast adjusted to aide in visualizing the IHC stain.
Scale bar equals 50 mm.
(TIF)
Figures S6 Correlation plots between IBA-1 expression
and CD68 expression or morphometric descriptors. (A)
Correlation plots between the intensity of IBA-1 and CD68
expression for control, 1, 2, and 4 mg/kg doses. (B) Correlation
plots for all morphological parameters vs. IBA-1 expression for
control, 1 mg/kg, 2 mg/kg, and 4 mg/kg doses. Value indicates
the mean linear correlation coefficient (R
2) for dataset with n=7,
5, 5 and 6 animals, respectively.
(TIF)
Figure S7 The influence of resolution in X, Y, and Z
axes on segmentation and soma size estimates. The role
of resolution on microglia soma size detection was explored. When
the Z step size was changed from 1 mmt o2mm, or when pixel size
was changed from 0.76 mm/pixel to 1.33 mm/pixel, a negligible
change in mean soma size was detected. However, individual cells
may or may not be segmented depending on conditions as the
exact sections used may reveal cell-cell contacts. Scale bar equals
50 mm.
(TIF)
Figure S8 Soma size tracks microglia activation under
laser ablation conditions. A mouse had cranial window
surgery as described in methods, 2 weeks before the experiment,
and was injected with AngioSense 680 prior to imaging. Three
neighboring 245 mm6245 mm640 mm (XYZ) volumes
(zoom=1.5, 5126512 pixels spaced 2 mm in Z) were selected,
with a single site of focal damage per volume. Pixel size was
0.47 mm/pixel. The zoom was used to limit the analysis area to the
region immediately next to the site of ablation. A focused laser
beam of approximately 200 mW with a dwell time of 10 ms/pixel
was used to irradiate a microglial cell in the center of the imaging
area. Successful laser ablation was confirmed by observing
microglia processes extending to the damaged area, as in Davalos
et al. [22]. (A) Fold change in soma size over days after laser
ablation on day 0 (immediately after ablation) then at 24 h, 48 h,
and 72 h, averaged over the 3 volumes representing 36 individual
microglia. (B) Blood vessels are filled with red (AngioSense 680)
and microglia are in green (EGFP). The border colors on the
microglia indicate soma size, red corresponds to microglia with
soma size .65 mm
2, thus activated. Scale bar equals 50 mm.
(TIF)
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